Pharmacoresistant epilepsy associated with mutations in the KCNB1 and RELN genes. A case report

Katerelos, Adamantios; Zagkos, Nikolaos; Alexopoulou, Dimitra; Mouskou, Stella; Korona, Anastasia; Manolakos, Emmanouil

doi:10.21307/joepi-2020-006

Abstract

Introduction. Epilepsy is one of the most common neurological disorders worldwide. In most cases, epilepsy can be well managed. However, there is a number of patients who do not respond well enough to common medical treatments; a situation known as pharmacoresistant epilepsy. It can be caused by mechanisms that may involve environmental and genetic factors, as well as disease or drug related factors. Case presentation. Herein we present a case report of a six-year-old girl who has been diagnosed with pharmacoresistant epilepsy, characterized by generalized and focal seizures while she was on two antiepileptic drugs. Molecular testing, with Next Generation Sequencing (NGS) technique, revealed mutations at KCNB1 and RELN genes.

References

Bosch C., Muhaisen A., Pujadas L., Soriano E., Martínez A.: Reelin Exerts Structural, Biochemical and Transcriptional Regulation Over Presynaptic and Postsynaptic Elements in the Adult Hippocampus. Frontiers in Cellular Neuroscience, 2016, 10: 138.
Search in Google Scholar Back to article
Camfield P., Camfield C.: Incidence, prevalence and etiology of seizures and epilepsy in children. Epileptic Disord., 2015, 17: 117–123.
Search in Google Scholar Back to article
Cárdenas-Rodríguez N., Carmona-Aparicio L., Pérez-Lozano D.L., Ortega-Cuellar D., Gómez-Manzo S., Ignacio-Mejía I.: Genetic variations associated with pharmacoresistant epilepsy. Mol. Med. Rep., 2020, 21: 1685–1701.
Search in Google Scholar Back to article
Choi H., Hayat M.J., Zhang R., Hirsch L.J., Bazil C.W., Mendiratta A. et al.: Drug resistant epilepsy in adults: Outcome trajectories after failure of two medications. Epilepsia, 2016, 57: 1152–1160.
Search in Google Scholar Back to article
Depondt C.: The potential of pharmacogenetics in the treatment of epilepsy. Eur. J. Paediatr. Neurol., 2006, 10: 57–65.
Search in Google Scholar Back to article
Dutta S., Gangopadhyay P.K., Sinha S., Chatterjee A., Ghosh S., Rajamma U.: An association analysis of reelin gene (RELN) polymorphisms with childhood epilepsy in eastern Indian population from West Bengal. Cell Mol. Neurobiol., 2011, 31: 45–56.
Search in Google Scholar Back to article
Fiest K.M., Sauro K.M., Wiebe S., Patten S.B., Kwon C.-S., Dykeman J. et al.: Prevalence and incidence of epilepsy. Neurology, 2017, 88: 296–303.
Search in Google Scholar Back to article
Kalilani L., Sun X., Pelgrims B., Noack-Rink M., Villanueva V.: The epidemiology of drug-resistant epilepsy: A systematic review and meta-analysis. Epilepsia, 2018. https://doi.org/10.1111/epi.14596
Search in Google Scholar Back to article
Hong S.E., Shugart Y.Y., Huang D.T., Shahwan S.A., Grant P.E., Hourihane J.O. et al.: Autosomal recessive lissencephaly with cerebellar hypoplasia is associated with human RELN mutations. Nat. Genet., 2000, 26: 93–96.
Search in Google Scholar Back to article
Kang, S.K., Vanoye C.G., Misra S.N., Echevarria D.M., Calhoun J.D., O’Connor J.B. et al.: High throughput Characterization of KCNB1 variants Associated with Developmental and Epileptic Encephalopathy. Bio Rxiv., 2019, 86: 899–912.
Search in Google Scholar Back to article
Kovel, C.G.F de, Syrbe S., Brilstra E.H., Verbeek N., Kerr B., Dubbs H. et al.: Neurodevelopmental Disorders Caused by de Novo Variants in KCNB1 Genotypes and Phenotypes. JAMA Neurol., 2017, 74: 1228–1236.
Search in Google Scholar Back to article
Kwan P., Brodie M.J.: Early identification of refractory epilepsy. N. Engl. J. Med., 2000, 342: 314–319.
Search in Google Scholar Back to article
Kwan P., Arzimanoglou A., Berg A.T., Brodie M.J., Allen Hauser W., Mathern G. et al.: Definition of drug resistant epilepsy: Consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies. Epilepsia, 2010, 51: 1069–1077.
Search in Google Scholar Back to article
López González F.J., Rodríguez Osorio X., Gil-Nagel Rein A., Carreño Martínez M., Serratosa Fernández J., Villanueva Haba V. et al.: Drug-resistant epilepsy: Definition and treatment alternatives. Neurologia, 2015, 30: 439–446. (In English, Spanish).
Search in Google Scholar Back to article
Luciano A.L., Shorvon S.D.: Results of treatment changes in patients with apparently drug-resistant chronic epilepsy. Ann. Neurol., 2007, 62: 375–381.
Search in Google Scholar Back to article
Marini, C., Romoli M., Parrini E., Costa C., Mei D., Mari F. et al.: Clinical features and outcome of 6 new patients carrying de novo KCNB1 gene mutations. Neurol. Genet., 2017, 3: e206.
Search in Google Scholar Back to article
Michelucci R., Pulitano P., Di Bonaventura C., Binelli S., Luisi C., Pasini E. et al.: The clinical phenotype of autosomal dominant lateral temporal lobe epilepsy related to reelin mutations. Epilepsy Behav., 2017, 68: 103–107.
Search in Google Scholar Back to article
Myers C.T., Mefford H.C.: Advancing epilepsy genetics in the genomic era. Genome Med., 2015, 7: 91.
Search in Google Scholar Back to article
Sun Y., Seneviratne U., Perucca P., Chen Z., Tan M.K., O’Brien T.J. et al.: Generalized polyspike train: An EEG biomarker of drug-resistant idiopathic generalized epilepsy. Neurology, 2018, 91: e1822–e1830.
Search in Google Scholar Back to article
Szaflarski J.P., Lindsell C.J., Zakaria T., Banks C., Privitera M.D.: Seizure control in patients with idiopathic generalized epilepsies: EEG determinants of medication response. Epilepsy Behav., 2010, 17: 525–530.
Search in Google Scholar Back to article
Téllez-Zenteno J.F., Hernández-Ronquillo L., Buckley S., Zahagun R., Rizvi S.: A validation of the new definition of drug-resistant epilepsy by the International League Against Epilepsy. Epilepsia, 2014, 55: 829–834.
Search in Google Scholar Back to article
Torkamani, A., Bersell K., Jorge B.S., Bjork R.L. Jr, Friedman J.R., Bloss C.S. et al.: De novo KCNB1 mutations in epileptic encephalopathy. Ann. Neurol., 2014, 76: 529–540.
Search in Google Scholar Back to article

Pharmacoresistant epilepsy associated with mutations in the KCNB1 and RELN genes. A case report

Abstract

Paradigm

My account